Shitara Y, Kato Y, Sugiyama Y
Faculty of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
J Control Release. 1998 Oct 30;55(1):35-43. doi: 10.1016/s0168-3659(98)00025-x.
To regulate intracellular sorting of epidermal growth factor (EGF) or transferrin (Tf), the effect of brefeldin A (BFA) or lysosomotropic reagents was investigated. To examine the effect of them on the net transcellular transport of 125I-EGF or 125I-Tf, their transcytosis was investigated in the presence or absence of reagents. For the investigation of their fate after internalization, radiolabeled ligands were internalized at 37 degreesC, followed by extensive washing and subsequent incubation at 37 degreesC in the ligand-free medium (pulse-chase study). BFA enhanced transcytosis of 125I-Tf, but had no effect on 125I-EGF. Kinetic analysis in the pulse-chase study showed that BFA does not affect cell-surface binding or intracellular sorting of EGF, while it only increases the transcytosis rate constant of Tf. From the lysosomotropic reagents study, both ammonium chloride and monensin suppressed transcytosis and recycling as well as the degradation of EGF, while both chloroquine and bafilomycin A selectively suppressed the degradation process with only a minimal effect on transcytosis, resulting in an increase in the amount transcytosed. It is concluded the that enhancement effect of BFA on transcytosis depends upon the type of receptor targeted. Lysosomotropic reagents can be divided into two types as far as the specificity of the effect on the net amount of EGF transcytosed in Madin-Darby canine kidney (MDCK) cells is concerned.
为了调控表皮生长因子(EGF)或转铁蛋白(Tf)的细胞内分选,研究了布雷菲德菌素A(BFA)或溶酶体促渗剂的作用。为了检测它们对125I-EGF或125I-Tf跨细胞净转运的影响,在有或无试剂存在的情况下研究了它们的转胞吞作用。为了研究内化后它们的去向,将放射性标记的配体在37℃内化,随后充分洗涤,并在无配体培养基中于37℃继续孵育(脉冲追踪研究)。BFA增强了125I-Tf的转胞吞作用,但对125I-EGF没有影响。脉冲追踪研究中的动力学分析表明,BFA不影响EGF的细胞表面结合或细胞内分选,而仅增加Tf的转胞吞速率常数。从溶酶体促渗剂研究来看,氯化铵和莫能菌素均抑制转胞吞作用、再循环以及EGF的降解,而氯喹和巴弗洛霉素A则选择性地抑制降解过程,对转胞吞作用影响极小,从而导致转胞吞量增加。得出的结论是,BFA对转胞吞作用的增强效应取决于所靶向的受体类型。就对Madin-Darby犬肾(MDCK)细胞中EGF转胞吞净量的影响特异性而言,溶酶体促渗剂可分为两类。